Dry Needling and Bobath Treatment Clinical Effects Focused on Stroke Patients
Ischemic Stroke, Spasticity
About this trial
This is an interventional treatment trial for Ischemic Stroke focused on measuring Muscle Spasticity, Dry Needling, Stroke
Eligibility Criteria
Inclusion Criteria:
- Medical diagnosis of unilateral ischemic Stroke
- Unilateral hemiplegia resulting from Stroke
- Evolution of at least 6 months since the Stroke
- Age between 35 and 81 years of age
- Presence of hypertonia in the upper extremity
- Restricted shoulder range of motion
Exclusion Criteria:
- Recurrent Stroke
- Previous treatment with nerve blocks, motor point injections with neurolytic agents for Spasticity at any time, or with BTX-A in the previous 6 months
- Cognitive deficits
- Progressive or severe neurological diseases, eg, heart conditions, unstable hypertension, fractures or implants in upper extremity
- Belonephobia (fear to needles)
- Have received pharmacological treatment for shoulder pain 3 months before the study
- Existence of peripheral nerve injury
- Previous history of fracture in the gleno-humeral joint
- Episodes of epilepsy in the year prior to participation in the study
Sites / Locations
- Polibea Sur neurorehabilitation clinic
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Dry needling in a myofascial trigger points area
Dry needling in a non myofascial trigger points area
The intervention will consist of a sixty minutes physical therapy session based on the modulating Bobath technique focused on the upper limb. Besides, during the intervention patients will receive deep dry needling that will be inserted into trigger point spastic muscle of the shoulder.
The intervention will consist of a sixty minutes physical therapy session based on the modulating Bobath technique focused on the upper limb. Besides, during the intervention patients will receive deep dry needling that will be inserted into a non trigger point spastic muscle of the shoulder.